These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31622673)

  • 1. Emerging targets for cough therapies; NK1 receptor antagonists.
    Badri H; Smith JA
    Pulm Pharmacol Ther; 2019 Dec; 59():101853. PubMed ID: 31622673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitussive activity of the tachykinin NK1 receptor antagonist, CP-99994, in dogs.
    Chapman RW; House A; Liu F; Celly C; Mei H; Hey JA
    Eur J Pharmacol; 2004 Feb; 485(1-3):329-32. PubMed ID: 14757157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the two tachykinin antagonists, SR 48968 and SR 140333, on cough induced by citric acid in the unanaesthetized guinea pig.
    Girard V; Naline E; Vilain P; Emonds-Alt X; Advenier C
    Eur Respir J; 1995 Jul; 8(7):1110-4. PubMed ID: 7589394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprepitant for Cough in Lung Cancer. A Randomized Placebo-controlled Trial and Mechanistic Insights.
    Smith JA; Harle A; Dockry R; Holt K; Russell P; Molassiotis A; Yorke J; Robinson R; Birrell MA; Belvisi MG; Blackhall F
    Am J Respir Crit Care Med; 2021 Mar; 203(6):737-745. PubMed ID: 32966755
    [No Abstract]   [Full Text] [Related]  

  • 5. The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant.
    Coveñas R; Rodríguez FD; Robinson P; Muñoz M
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of NK-1R using aprepitant suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes.
    Liu X; Zhu Y; Zheng W; Qian T; Wang H; Hou X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1628-1634. PubMed ID: 31010320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential therapeutic targets for neurokinin-1 receptor antagonists.
    Duffy RA
    Expert Opin Emerg Drugs; 2004 May; 9(1):9-21. PubMed ID: 15155133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aprepitant for Cough Suppression in Advanced Lung Cancer: A Randomized Trial.
    Noronha V; Bhattacharjee A; Patil VM; Joshi A; Menon N; Shah S; Kannan S; Mukadam SA; Maske K; Ishi S; Prabhash K
    Chest; 2020 Jun; 157(6):1647-1655. PubMed ID: 31958446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesis.
    Rojas C; Raje M; Tsukamoto T; Slusher BS
    Eur J Pharmacol; 2014 Jan; 722():26-37. PubMed ID: 24184669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
    Anthes JC; Chapman RW; Richard C; Eckel S; Corboz M; Hey JA; Fernandez X; Greenfeder S; McLeod R; Sehring S; Rizzo C; Crawley Y; Shih NY; Piwinski J; Reichard G; Ting P; Carruthers N; Cuss FM; Billah M; Kreutner W; Egan RW
    Eur J Pharmacol; 2002 Aug; 450(2):191-202. PubMed ID: 12206858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Mechanism of Endoplasmic Reticulum Stress- and c-Myc-Degradation-Mediated Therapeutic Benefits of Antineurokinin-1 Receptor Drugs in Colorectal Cancer.
    Shi Y; Wang X; Meng Y; Ma J; Zhang Q; Shao G; Wang L; Cheng X; Hong X; Wang Y; Yan Z; Cao Y; Kang J; Fu C
    Adv Sci (Weinh); 2021 Nov; 8(21):e2101936. PubMed ID: 34605226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of substance P and tachykinin receptor antagonists in citric acid-induced cough in pigs.
    Moreaux B; Nemmar A; Vincke G; Halloy D; Beerens D; Advenier C; Gustin P
    Eur J Pharmacol; 2000 Nov; 408(3):305-12. PubMed ID: 11090648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid induces kaolin intake stimulating a pathway involving tachykinin neurokinin 1 receptors in rats.
    Kakiuchi H; Kawarai-Shimamura A; Kuwagata M; Orito K
    Eur J Pharmacol; 2014 Jan; 723():1-6. PubMed ID: 24333477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors.
    Kolorz J; Demir S; Gottschlich A; Beirith I; Ilmer M; Lüthy D; Walz C; Dorostkar MM; Magg T; Hauck F; von Schweinitz D; Kobold S; Kappler R; Berger M
    Curr Oncol; 2021 Dec; 29(1):94-110. PubMed ID: 35049682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.
    Jacob D; Busciglio I; Burton D; Halawi H; Oduyebo I; Rhoten D; Ryks M; Harmsen WS; Camilleri M
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G505-G510. PubMed ID: 28814387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate.
    Di Fabio R; Alvaro G; Braggio S; Carletti R; Gerrard PA; Griffante C; Marchioro C; Pozzan A; Melotto S; Poffe A; Piccoli L; Ratti E; Tranquillini E; Trower M; Spada S; Corsi M
    Bioorg Med Chem; 2013 Nov; 21(21):6264-73. PubMed ID: 24075145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future prospects for drugs to suppress cough.
    Chung KF
    IDrugs; 2003 Aug; 6(8):781-6. PubMed ID: 12917774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rolapitant hydrochloride: prophylactic treatment for chemotherapy-induced nausea and vomiting.
    Navari R
    Drugs Today (Barc); 2016 Aug; 52(8):431-438. PubMed ID: 27722211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of T-2328, 2-fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile dihydrochloride, as a brain-penetrating antagonist of tachykinin NK1 receptor.
    Watanabe Y; Asai H; Ishii T; Kiuchi S; Okamoto M; Taniguchi H; Nagasaki M; Saito A
    J Pharmacol Sci; 2008 Jan; 106(1):121-7. PubMed ID: 18187929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of SP/Neurokinin-1 as a Therapeutic Target in Colon and Rectal Cancer.
    Martín-García D; Téllez T; Redondo M; García-Aranda M
    Curr Med Chem; 2024; 31(39):6487-6509. PubMed ID: 37861026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.